SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950142-06-000334
Filing Date
2006-02-14
Accepted
2006-02-14 16:34:23
Documents
4
Group Members
FRANK H. PEARLGEORGE SOROSPERSEUS BIOTECH FUND PARTNERS, LLCPERSEUS-SOROS BIOPHARMACEUTICAL FUND, L.P.PERSEUS-SOROS PARTNERS, LLCPERSEUSPUR, LLCSFM AH LLCSFM PARTICIPATION, L.P.SOROS FUND MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 sc13ga3-allos.txt SC 13G/A 35190
2 EXHIBIT 1 ex_1sc13ga3-allos.txt EX-99 6407
3 EXHIBIT 2 ex_2sc13ga3-allos.txt EX-24 2755
4 EXHIBIT 3 ex_3sc13ga3-allos.txt EX-24 2349
  Complete submission text file 0000950142-06-000334.txt   49202
Mailing Address 888 SEVENTH AVE 33RD FLR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 212-262--6
SOROS GEORGE (Filed by) CIK: 0000900203 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 11080 CIRCLEPOINT ROAD SUITE 200 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 200 WESTMINSTER CO 80020 3034266262
ALLOS THERAPEUTICS INC (Subject) CIK: 0001097264 (see all company filings)

IRS No.: 541655029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60251 | Film No.: 06615911
SIC: 2834 Pharmaceutical Preparations